Kalaris Therapeutics logo

Kalaris Therapeutics Share Price Today

(NASDAQ: KLRS)

Kalaris Therapeutics share price is $6.99 & ₹597.40 as on 18 Apr 2025, 2.30 'hrs' IST

$6.99

0.29

(4.33%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Kalaris Therapeutics share price in Dollar and Rupees. Guide to invest in Kalaris Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kalaris Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Kalaris Therapeutics share price movements

  • Today's Low: $6.52
    Today's High: $7.31

    Day's Volatility :10.81%

  • 52 Weeks Low: $5.87
    52 Weeks High: $12.90

    52 Weeks Volatility :54.53%

Kalaris Therapeutics (KLRS) Returns

PeriodKalaris Therapeutics IncIndex (Russel 2000)
3 Months
-25.48%
0.0%
6 Months
-60.79%
0.0%
1 Year
-59.49%
0.0%
3 Years
-95.14%
-12.9%

Kalaris Therapeutics (KLRS) Key Statistics

in dollars & INR

Previous Close
$6.7
Open
$6.52
Today's High
$7.31
Today's Low
$6.52
Today's Volume
$19.2K
52 Week High
$12.9
52 Week Low
$5.865
Revenue TTM
$0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Kalaris Therapeutics Stock (KLRS) from India?

It is very easy for Indian residents to invest directly in Kalaris Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kalaris Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kalaris Therapeutics or KLRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kalaris Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kalaris Therapeutics shares which would translate to 0.122 fractional shares of Kalaris Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kalaris Therapeutics, in just a few clicks!

Returns in Kalaris Therapeutics (KLRS) for Indian investors in Rupees

The Kalaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kalaris Therapeutics investment value today

Current value as on today

₹42,863

Returns

₹57,137

(-57.14%)

Returns from Kalaris Therapeutics Stock

₹59,478 (-59.48%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Kalaris Therapeutics (KLRS)

-30%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Kalaris Therapeutics Stock from India on INDmoney has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Kalaris Therapeutics

Rating
Trend

Insights on Kalaris Therapeutics Stock (Ticker Symbol: KLRS)

  • Price Movement

    In the last 7 days, KLRS stock has moved down by -7.3%
  • KLRS vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 137.3%
  • KLRS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 123.5%

Kalaris Therapeutics Technicals Summary

Sell

Neutral

Buy

Kalaris Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Kalaris Therapeutics (KLRS) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kalaris Therapeutics Inc logo
-41.23%
-60.79%
-59.49%
-95.14%
-98.8%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Kalaris Therapeutics

Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.
Organization
Kalaris Therapeutics
Employees
14
CEO
Mr. Andrew Oxtoby
Industry
Miscellaneous

Management People of Kalaris Therapeutics

NameTitle
Mr. Andrew Oxtoby
President, CEO & Director
Dr. Srinivas Akkaraju M.D., Ph.D.
Director & Co-Founder
Dr. Michael Philip Dybbs Ph.D.
Director & Co-Founder
Dr. Napoleone Ferrara M.D.
Director & Co-Founder
Dr. Samir C. Patel M.D.
Director & Co-Founder
Mr. Brett R. Hagen
Principal Financial Officer & Principal Accounting Officer
Dr. Jeffrey Nau MMS, Ph.D.
Chief Operating Officer
Dr. Matthew Feinsod M.D.
Chief Medical Officer

Important FAQs about investing in KLRS Stock from India :

What is Kalaris Therapeutics share price today?

Kalaris Therapeutics share price today stands at $6.99, Open: $6.52 ; Previous Close: $6.70 ; High: $7.31 ; Low: $6.52 ; 52 Week High: $12.90 ; 52 Week Low: $5.87.

The stock opens at $6.52, after a previous close of $6.70. The stock reached a daily high of $7.31 and a low of $6.52, with a 52-week high of $12.90 and a 52-week low of $5.87.

Can Indians buy Kalaris Therapeutics shares?

Yes, Indians can invest in the Kalaris Therapeutics (KLRS) from India.

With INDmoney, you can buy Kalaris Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kalaris Therapeutics at zero transaction cost.

How can I buy Kalaris Therapeutics shares from India?

It is very easy to buy Kalaris Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kalaris Therapeutics (KLRS) be purchased?

Yes, you can buy fractional shares of Kalaris Therapeutics with INDmoney app.

What are the documents required to start investing in Kalaris Therapeutics stocks?

To start investing in Kalaris Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kalaris Therapeutics Stock (KLRS)?

Today’s highest price of Kalaris Therapeutics (KLRS) is $7.31.

Today’s lowest price of Kalaris Therapeutics (KLRS) is $6.52.

What is today's market capitalisation of Kalaris Therapeutics?

Today's market capitalisation of Kalaris Therapeutics KLRS is

What is the 52 Week High and Low Range of Kalaris Therapeutics Stock (KLRS)?

  • 52 Week High

    $12.90

  • 52 Week Low

    $5.87

What are the historical returns of Kalaris Therapeutics (KLRS)?

  • 1 Month Returns

    -41.23%

  • 3 Months Returns

    -60.79%

  • 1 Year Returns

    -59.49%

  • 5 Years Returns

    -98.8%

Who is the Chief Executive Officer (CEO) of Kalaris Therapeutics ?

Mr. Andrew Oxtoby is the current Chief Executive Officer (CEO) of Kalaris Therapeutics.